HPV Infection Vaccine Safety SCT1000
1 clinical trials · Condition
◉ Watch HPV Infection Vaccine Safety SCT1000
| Record | Firm | Date |
|---|---|---|
| A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years (NCT04921111) | Sinocelltech Ltd. | 2021-07-02 |
Track HPV Infection Vaccine Safety SCT1000 automatically
Every clearance here is in the API, with alerts when new ones post.